Exogenus Therapeutics is committed to giving back to the scientific community, by sharing what we learn along the way. Aside from accepting trainees and PhD students, Exogenus cultivates a culture of publishing in peer-reviewed journals. Additionally, our staff regularly contributes to conferences, often at the invite of the organizers.

DISSEMINATIONS

SCIENTIFIC PUBLICATIONS:
Cardoso RMS, Rodrigues SC, Gomes CF, Duarte FV, Romao M, Leal EC, Freire PC, Neves R, Correia JS. Development of an optimized and scalable method for isolation of umbilical cord blood-derived small extracellular vesicles for future clinical use. STEM CELLS Transl Med. 2021; 1-12. doi: 10.1002/sctm.20-0376

Link to publication

 

INVITED TALKS:

Correia, J. Pre-clinical Development of Exosome-Based Therapeutics: Challenges, Barriers & Opportunities. 2nd Exosome Based Therapeutic Development Summit, 2020, Nov 12; Virtual

Correia, J. Therapeutic potential of UCB-derived extracellular vesicles. World Advanced Therapies and Regenerative Medicine Congress, 2019, May 17; London, UK

Correia, J. Umbilical Cord Blood supply for the development of Exo-Wound, an exosome-based product for Chronic Wounds. World Cord Blood Europe, 2017, May 17; London, UK

POSTERS:

Rodrigues, S. Development of a Standardized Exosomes Production Process for Clinical Use. International Society for Extracellular Vesicles (ISEV) Meeting, 2018, May 2-6; Barcelona, Spain

Link to the poster

 

Rodrigues, S. The Impact of Automatizing Umbilical Cord Blood Processing in the Production of an Exosome-Based Medicinal Product. 1st Vesicular Biology Meeting, 2018, 16-17; Coimbra, Portugal

Link to the poster

 

PATENTS & LICENSES

WO/2017/163132 – Use of Umbilical Cord Blood Derived Exosomes for Tissue Repair (Exclusive License)

 

WO/2020/070700 – Compositions Comprising Small Extracellular Vesicles Derived from Umbilical Cord Blood Mononuclear Cells with Anti-Inflammatory and Immunomodulatory Properties